Hypocalcemia Management

Introduction to Hypocalcemia

The patient presents with symptomatic hypocalcemia, characterized by perioral paresthesia and muscle twitching, with an ionized calcium level of 0.9 mmol/L, which is below the normal range of 1.1-1.3 mmol/L, indicating the need for immediate intervention 1

The patient's active neuromuscular symptoms indicate symptomatic hypocalcemia that requires immediate intervention, as stated by current guidelines, with a strength of evidence supporting rapid correction to prevent progression to more severe manifestations 1
Calcium chloride is the preferred agent for treating acute symptomatic hypocalcemia, providing more elemental calcium than calcium gluconate, with 10 mL of 10% calcium chloride containing 270 mg of elemental calcium, compared to only 90 mg in 10 mL of 10% calcium gluconate, according to the American College of Critical Care 1

Administer 1 g calcium chloride IV over 5 minutes with ECG monitoring, and monitor ionized calcium levels 4-6 hours after administration, as recommended by the American College of Critical Care 1
Continue to monitor for symptom resolution and potential complications, such as hypercalcemia, which can cause nausea, vomiting, and altered mental status 4

Oral calcium is inappropriate for acute symptomatic hypocalcemia requiring immediate correction, as absorption would be too slow to address current symptoms, according to the American Journal of Kidney Diseases 2
Calcium carbonate 500 mg orally three times daily may cause constipation as a side effect, and is not suitable for acute treatment, as stated by the American Journal of Kidney Diseases, although the side effect information is also available from Praxis Medical Insights, the primary source is used here 2

Consider oral calcium and vitamin D supplementation after the acute phase if hypocalcemia persists, as recommended by Genetics in Medicine 4
Monitor for signs of hypercalcemia during treatment, and avoid overcorrection of calcium levels, which can lead to iatrogenic hypercalcemia, renal calculi, and renal failure, with a strength of evidence supporting careful monitoring and adjustment of treatment 4